Stockscreener 앱 받기
2.244
3.23%
0.074
전일 마감가:
$2.17
열려 있는:
$2.18
하루 거래량:
80,583
Relative Volume:
0.11
시가총액:
$159.69M
수익:
-
순이익/손실:
$-104.08M
주가수익비율:
-1.595
EPS:
-1.4069
순현금흐름:
$-89.91M
1주 성능:
-5.08%
1개월 성능:
-0.88%
6개월 성능:
-0.88%
1년 성능:
+42.22%
1일 변동 폭
$2.18
$2.24
1주일 범위
$2.13
$2.40
52주 변동 폭
$1.598
$2.81
엔카르타 Stock (NKTX) Company Profile
명칭
Nkarta Inc
전화
(925) 407-1049
주소
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Compare NKTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.24 | 154.70M | 0 | -104.08M | -89.91M | -1.4069 |
VRTX
Vertex Pharmaceuticals Inc
|
440.96 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.12 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
803.42 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.90 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.41 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
엔카르타 Stock (NKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | 개시 | Rodman & Renshaw | Buy |
| 2024-08-14 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 개시 | Canaccord Genuity | Buy |
| 2022-07-28 | 개시 | Needham | Buy |
| 2022-07-18 | 개시 | SVB Leerink | Outperform |
| 2022-03-11 | 개시 | Raymond James | Outperform |
| 2022-03-08 | 개시 | H.C. Wainwright | Buy |
| 2022-01-06 | 개시 | William Blair | Outperform |
| 2021-11-18 | 개시 | SMBC Nikko | Outperform |
| 2021-07-16 | 개시 | Oppenheimer | Outperform |
| 2020-08-04 | 개시 | Cowen | Outperform |
| 2020-08-04 | 개시 | Evercore ISI | Outperform |
| 2020-08-04 | 개시 | Mizuho | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
엔카르타 주식(NKTX)의 최신 뉴스
CEO Moves: Will Nkarta Inc stock benefit from M A2026 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
If You Invested $1,000 in Nkarta, Inc. (NKTX) - Stock Titan
Aug PostEarnings: Is Nkarta Inc stock suitable for long term investing2026 Big Picture & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Nkarta to Participate in Needham Virtual Healthcare Conference - Bitget
Nkarta leaders to discuss autoimmune cell therapy at Needham event - Stock Titan
Ideas Watch: Does Nkarta Inc have declining or rising EPSGap Down & High Win Rate Trade Tips - baoquankhu1.vn
Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight - GlobeNewswire Inc.
Layoff Watch: What analysts say about Nkarta Inc stock2026 Technicals & Real-Time Buy Zone Alerts - baoquankhu1.vn
Nkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
[EFFECT] Nkarta, Inc. SEC Filing - Stock Titan
Nkarta (NASDAQ: NKTX) launches $100M ATM shelf via Stifel as sales agent - Stock Titan
NKTX Technical Analysis & Stock Price Forecast - Intellectia AI
Nkarta (NASDAQ:NKTX) Price Target Lowered to $12.00 at Mizuho - Defense World
NKTX PE Ratio & Valuation, Is NKTX Overvalued - Intellectia AI
Mizuho lowers Nkarta stock price target on sales ramp moderation - Investing.com
Mizuho lowers Nkarta stock price target on sales ramp moderation By Investing.com - Investing.com India
HC Wainwright Forecasts Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World
HC Wainwright Forecasts Nkarta's Q1 Earnings (NASDAQ:NKTX) - MarketBeat
Nkarta files $350M shelf offering, plans $100M ATM stock sale via Stifel - MSN
Nkarta (NASDAQ:NKTX) Rating Lowered to Sell at Wall Street Zen - MarketBeat
TD Cowen Maintains Nkarta(NKTX.US) With Buy Rating - Moomoo
Risk Hedge: Will Nkarta Inc stock go up in YEARPortfolio Performance Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), QT Imaging Holdings (QTI) and Cardiff Oncology (CRDF) - The Globe and Mail
Nkarta Launches $100 Million At-the-Market Stock Offering - The Globe and Mail
Nkarta (NASDAQ:NKTX) Price Target Raised to $11.00 at Needham & Company LLC - Defense World
Nkarta, Inc. Files Form 8-K With SEC Detailing Company and Stock Information – March 25, 2026 - Minichart
NKTX (Nkarta) PB Ratio : 0.51 (As of Mar. 26, 2026) - GuruFocus
Nkarta (NASDAQ:NKTX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Stifel reiterates Nkarta stock rating on trial enrollment progress By Investing.com - Investing.com South Africa
Stifel reiterates Nkarta stock rating on trial enrollment progress - Investing.com
Nkarta launches $100M at-the-market equity program with Stifel - TradingView
Nkarta, Inc. 2025 Annual Report: Advancing Allogeneic CAR NK-Cell Therapies for Cancer and Autoimmune Diseases - Minichart
Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aug Momentum: Should value investors consider Nkarta Inc2026 Institutional & Real-Time Volume Triggers - baoquankhu1.vn
Nkarta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Nkarta (NASDAQ: NKTX) launches $100M at-the-market stock sale plan - Stock Titan
Nkarta Files $350 Million Mixed Shelf - marketscreener.com
Nkarta (NASDAQ: NKTX) launches $100M at-the-market program via $350M shelf - Stock Titan
Nkarta (NASDAQ:NKTX) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
Nkarta 2025 10-K: Net loss $104.1M, EPS $(1.41) - TradingView
[10-K] Nkarta, Inc. Files Annual Report - Stock Titan
Nkarta (NASDAQ: NKTX) reports 2025 loss and extends cash runway to 2029 - stocktitan.net
Nkarta reports fourth quarter and full year 2025 financial results and corporate highlights - MarketScreener
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights - The Globe and Mail
Nkarta (NKTX) to Release Earnings on Tuesday - Defense World
Trend Report: Is Nkarta Inc stock a buy or sell2026 Levels & Reliable Intraday Trade Plans - baoquankhu1.vn
Nkarta Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
NKTX Q4'25 Earnings: EPS estimate is (0.31) USD - tradingview.com
Trading Action: Will Nkarta Inc face regulatory challenges2026 Pullback Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
Street Watch: Will Nkarta Inc stock go up in YEAR2026 Volatility Report & Fast Moving Stock Watchlists - baoquankhu1.vn
Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
엔카르타 (NKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엔카르타 주식 (NKTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mahmood Nadir | President |
Jan 15 '26 |
Sale |
2.07 |
5,649 |
11,693 |
167,727 |
| HASTINGS PAUL J | Chief Executive Officer |
Jun 18 '25 |
Sale |
1.79 |
1,790 |
3,204 |
320,069 |
0.62%
자본화:
|
볼륨(24시간):